- Citations, last 5 years
- 199k
- Works, last 5 years
- 15.7k
- h-index
- 1,134
- Scientists listed
- 827
- Grants since 2016
- 1 652
Grants received
2017–2022 · cooperative agreement · U01
Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit
Michael Birrer · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Predicting PrEP Uptake and Adherence among Adolescent Girls and Young Women in Sub-Saharan Africa: Leveraging Programmatic and Clinical Trials Data
Ying Qing Chen · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Differentiation balances oncogene-driven proliferation to maintain epidermal homeostasis
Slobodan Beronja · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Differentiation balances oncogene-driven proliferation to maintain epidermal homeostasis
Slobodan Beronja · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2023 · cooperative agreement · UH3
ReCAPSE: Recurrence from Claims And PROs for SEER Enhancement
Jessica Chubak · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R50
Advanced statistical modeling and analytics for prostate cancer interventions
Roman Gulati · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2021 · research · R01
Molecular pathoepidemiology of contralateral breast cancer
Jonine L. Bernstein · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Personalized cancer models to discover and develop new therapeutic targets.
Christopher J Kemp · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit
Michael Birrer · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2021 · research · R01
High-resolution modeling of protein-RNA interfaces
Philip Bradley · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Comprehensive Colorectal Cancer Risk Prediction to Inform Personalized Screening
Douglas Allen Corley · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2021 · research · R01
Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy
Eric Jessen Chow · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Generating rapid antitumor immunity with lymphocyte-reprogramming nanocarriers
Matthias Stephan · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Whole Genome Sequence Analysis of Ischemic Stroke in the Women's Health Initiative
Charles L Kooperberg · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Identification of Novel Mucosal Immune Mechanisms Involved in Protection from HIV-1
Jairam Rao Lingappa · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Improving treatment of cardiovascular risk factors in childhood cancer survivors
Eric Jessen Chow · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2019 · research · R21
Engineered CTLA4-targeted agonists as therapeutic immunomodulators
Roland K Strong · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Generating rapid antitumor immunity with lymphocyte-reprogramming nanocarriers
Matthias Stephan · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Delineating the mechanisms and clinical utility of mtDNA mutagenesis in cancer
Jason H Bielas · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2019 · fellowship · F32
The effect of local inter-nucleosomal interactions and chromatin remodeling on in vivo chromatin fiber folding
Sarah Grace Swygert · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial
Margaret M Madeleine · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2021 · research · R01
Rational design and functionalization of circular tandem repeat proteins
Philip Bradley · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R50
Defining and targeting mechanisms of pancreas cancer pathogenesis
Martin Whittle · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2018 · fellowship · F31
Characterization of DUX4-induced histone H3 variants
Rebecca May Resnick · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2020 · research · R01
Comprehensive Colorectal Cancer Risk Prediction to Inform Personalized Screening
Douglas Allen Corley · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.
William Mallory Grady · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · RC2
Niche signals in HSC genesis
Irwin D Bernstein · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
An Academic-Industry Partnership to Advance Functional Genomics for Personalized Oncology.
Christopher J Kemp · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Predicting PrEP Uptake and Adherence among Adolescent Girls and Young Women in Sub-Saharan Africa: Leveraging Programmatic and Clinical Trials Data
Ying Qing Chen · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2020 · research · R01
Novel Gene Editing Approaches for Hemoglobinopathies
Hans-Peter Kiem · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
The SyngenicDNA and μPOET Platform: Overcoming Innate Barriers to Genetic Engineering in Bacteria.
Christopher D Johnston · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Immuno and Epigenetics of Hematopoietic Cell Transplantation
Effie W Petersdorf · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · RC2
Niche signals in HSC genesis
Irwin D Bernstein · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R35
Investigating how cellular mechanisms interface to maintain energy balance
Akhila Rajan · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy
Eric Jessen Chow · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2021 · research · R01
Novel regulation of Notch-induced HSPC expansion
Irwin D Bernstein · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Integrating health informatics in a scalable stepped care self-management program for survivors after hematopoietic cell transplantation
Kevin S Baker · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Targeting a Novel Hematopoietic Stem Cell Population in Non-Human Primates for Effective and Sustained Gene Therapy
Hans-Peter Kiem · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R25
Pathways to Cancer Research
Jeanne Ting Chowning · Fred Hutch Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
The SyngenicDNA and ÃÂÃÂÃÂüPOET Platform: Overcoming Innate Barriers to Genetic Engineering in Bacteria.
Christopher D Johnston · Fred Hutch Cancer Center · funded by National Institutes of Health
